Abstract:Abstract BACKGROUND AND AIMS Patients with end-stage kidney disease (ESKD) face higher risk for severe outcomes from COVID-19 infection. Moreover, it is not well known to which extent potentially modifiable risk factors contribute to mortality risk. In this study, we investigated the incidence and risk factors for 30-day case-fatality of COVID-19 in haemodialysis patients treated in the European Fresenius Medical Care (FMC) Nephrocare network. METHOD In this historical cohort study, we included unvaccinated adult dialysis patients with a first documented SARS-CoV-2 infection between 1 February 2020 and 31 March 2021 (study period) registered in the European Clinical Database (EuCliD®). The first SARS-CoV-2 suspicion date for all documented infections was considered the index date for the analysis. Patients were followed for up to 30 days. Follow-up time was defined from the index date until the date of death, end of follow-up period or lost to follow-up, whichever occurred first. We ascertained patients’ characteristics in the 6-month period prior to index date. We used logistic regression and XGBoost to assess risk factors for 30-day mortality. RESULTS We included 9211 patients meeting the inclusion criteria for the study (Table 1). Age was 65.4 ± 13.7 years, dialysis vintage was 4.2 ± 3.7 years. In the follow up period, 1912 patients died within 30 days (20.8%, 95% confidence interval: 19.9%–21.6%). Correlates of COVID-19 related mortality are summarized in Table 2. Several potentially modifiable factors were associated with increased risk of death: patients on HD compared with online haemodiafiltration had shorter survival after presentation with COVID-19 as well as those who did not achieve the therapeutic targets for serum albumin, erythropoietin resistance index, protein catabolic rate, haemodynamic status, C-reactive protein, single-pool Kt/V, hydration status and serum sodium in the months before infection. The discrimination accuracy of prediction models developed with XGBoost was similar to that observed for main-effect logistic regression (AUC 0.69 and 0.71, respectively) suggesting that no major cross-interaction and non-linear effect could improve prediction accuracy. CONCLUSION We observed high 30-day COVID-19 related mortality among unvaccinated dialysis patients. Older patients, men and those with greater comorbidities had higher risk of death after COVID-19 infection. Derangement in potentially modifiable factors in the 6 months prior to COVID-19 infection was independently associated with increased mortality. Whether achievement of clinical therapeutic targets is associated with improved survival after COVID-19 infection is a matter of further research.

Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

SARS-CoV-2 and dialysis: humoral response, clinical and laboratory impacts before vaccination

End-stage kidney disease patients with severe coronavirus disease: clinical characteristics, biological data, and mortality in nephrology unit, short communication

Long-Term Interplay Between SARS-CoV-2 and Renal Impairment

End-Stage Renal Disease Patients on Chronic Hemodialysis Fare Better With COVID-19: A Retrospective Cohort Study From the New York Metropolitan Region

Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

Kidney Dysfunction and Its Progression in Patients Hospitalized Duo to COVID-19: Contribution to the Clinical Course and Outcomes

MO890: Modifiable and Non-Modifiable Factors Associated With Increased COVID-19 Related Mortality Among Dialysis Patients

Acute renal failure, COVID-19 and deaths, worrying rates in intensive care units: a cross-sectional study

Nephrology and Coronavirus Disease 2019

Clinical characteristics and outcomes in COVID-19 in kidney transplant recipients: a propensity score matched cohort study

Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients

COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea

COVID-19 and Chronic Renal Disease: Clinical Characteristics and Prognosis

Outcomes of patients with End Stage Kidney Disease on dialysis with COVID-19. From PCR to Antibody.

Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody

A multicenter study of severity and prognosis of symptomatic COVID‐19 in end‐stage renal disease and non‐dialysis patients in East of Iran

Risk factors for in-hospital mortality among patients hospitalized with COVID-19 and end-stage kidney disease

Patients with end-stage kidney disease and COVID-19 are commonly hospitalized early during COVID-19 illness: an opportunity for early intervention

Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury